Home›Compare›FeelGood vs Healthspan

FeelGood vs Healthspan: Which Is Better?

Head-to-head comparison of FeelGood and Healthspan based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Healthspan scores higher overall in our independent evaluation (71.3/100 vs 61/100), leading on trust & safety, experience, product range, reputation. FeelGood comes out ahead on value.

61

FeelGood is a 2026-launched, OpenLoop-powered GLP-1 brand whose promotional page offers compounded semaglutide from $89/mo and tirzepatide from $149/mo with no membership fee, alongside ED and 'longevity' microdose tirzepatide programs.

Visit FeelGood

Healthspan is a Santa Monica-based longevity clinic built around clinician-guided rapamycin protocols, with add-on hormone, metabolic and brand-name GLP-1 care under a $99/mo membership.

Visit Healthspan

Score Breakdown

DimensionFeelGoodHealthspan
Overall Score61/10071.3/100 ✓
Trust & Safety30%50/10072/100 ✓
Value25%80/100 ✓68/100
Experience20%65/10072/100 ✓
Product Range15%60/10074/100 ✓
Reputation10%40/10072/100 ✓

At a Glance

Founded20262019
HeadquartersSheridan, WYSanta Monica, CA
Publicly tradedNoNo
Treatment categories47
Treatments listed314
Starting price$75/mo$25/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryFeelGoodHealthspan
Weight Loss / GLP-1$75–$149
Compounded Semaglutide (injectable)
$248–$398
Wegovy Pill with Ongoing Care
Men's Health—$60
Enclomiphene
Longevity & Peptides—$25
Acarbose

FeelGood

+Promotional pricing is among the lowest tracked: compounded semaglutide $89/mo and tirzepatide $149/mo, with no membership fee and free shipping
+Clinical care is delivered through OpenLoop's established telehealth provider network
+Native iOS and Android apps plus 24/7 messaging support; HSA/FSA accepted
−Unsubstantiated marketing claims: '100,000+ patients' on a domain registered in February 2026, and a '2.4 years younger' epigenetic-age claim for microdose tirzepatide
−High-pressure sales tactics, including countdown timers, 'price increases soon' banners and 'only 9 spots left this month' prompts
−Prices vary across its own pages ($149 'starting' on the main site vs $89 on the offer page), so the price a patient gets depends on which landing page they arrive through
Read the full FeelGood review →

Healthspan

+Deepest rapamycin-centered longevity formulary we track: oral and topical rapamycin, SGLT2 inhibitors, metformin, acarbose, LDN and methylene blue
+Low entry pricing for core longevity drugs (rapamycin from $64/mo, metformin $27, acarbose $25), shown on the homepage
+Strong patient sentiment: 4.8/5 across ~402 Trustpilot reviews, with a founder who responds personally to negative reviews
−Brand-name GLP-1s require the $99+/mo membership on top of the medication cost ($299/mo Zepbound, $149/mo Wegovy pill)
−Longevity uses of rapamycin, SGLT2 inhibitors and metformin are off-label, and headline claims (e.g., an 8-year average biological-age reduction) are self-reported
−Dispensing pharmacy and medical group are not named on the public site
Read the full Healthspan review →

FeelGood vs Healthspan — FAQ

Is FeelGood better than Healthspan?

▾

Healthspan scores higher overall in our independent evaluation (71.3/100 vs 61/100), leading on trust & safety, experience, product range, reputation. FeelGood comes out ahead on value.

Is FeelGood or Healthspan cheaper?

▾

Healthspan has the lower starting price (from $25/mo vs $75/mo for FeelGood). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do FeelGood and Healthspan both offer?

▾

Both platforms treat Weight Loss / GLP-1, Men's Health, Longevity & Peptides. FeelGood covers 4 treatment categories total and Healthspan covers 7.

Still deciding?